Aptamers Industry Research Report 2024

Aptamers Industry Research Report 2024


Aptamers are high affinity molecules that are derived from RNA or DNA. These are normally generated using a synthetic process called “Systematic evolution of ligands by exponential enrichment” (SELEX).
Aptamers receive their name from the Latin word aptus meaning “fit”. This means they bind to the target molecules with high specificity and high affinity.
Aptamers are short nucleic acids that interact with a variety of targets with high affinity and specificity. They have been shown to inhibit biological functions of cognate target proteins, and they are identifiable by an in vitro selection process, also termed SELEX (Systematic Evolution of Ligands by EXponential enrichment). Being nucleic acids, aptamers can be synthesized chemically or enzymatically.

Highlights

The global Aptamers market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Global Aptamers key players include TriLink BioTechnologies, SomaLogic, AM Biotechnologies, Aptamer Sciences, Base Pair Biotechnologies etc. The Global top 10 manufacturers hold a share about 14%.North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 30% and 22%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aptamers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aptamers.
The Aptamers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aptamers market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aptamers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics

Product Type Insights

Global markets are presented by Aptamers type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Aptamers are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Aptamers segment by Type

DNA-Based Aptamers
RNA-Based Aptamers

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Aptamers market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Aptamers market.
Aptamers Segment by Application
Research and Development
Drug Discovery

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Aptamers market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aptamers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Aptamers and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Aptamers industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aptamers.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Aptamers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Aptamers by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
1.2.2 DNA-Based Aptamers
1.2.3 RNA-Based Aptamers
2.3 Aptamers by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Research and Development
2.3.3 Drug Discovery
2.4 Assumptions and Limitations
3 Aptamers Breakdown Data by Type
3.1 Global Aptamers Historic Market Size by Type (2019-2024)
3.2 Global Aptamers Forecasted Market Size by Type (2025-2030)
4 Aptamers Breakdown Data by Application
4.1 Global Aptamers Historic Market Size by Application (2019-2024)
4.2 Global Aptamers Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Aptamers Market Perspective (2019-2030)
5.2 Global Aptamers Growth Trends by Region
5.2.1 Global Aptamers Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Aptamers Historic Market Size by Region (2019-2024)
5.2.3 Aptamers Forecasted Market Size by Region (2025-2030)
5.3 Aptamers Market Dynamics
5.3.1 Aptamers Industry Trends
5.3.2 Aptamers Market Drivers
5.3.3 Aptamers Market Challenges
5.3.4 Aptamers Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Aptamers Players by Revenue
6.1.1 Global Top Aptamers Players by Revenue (2019-2024)
6.1.2 Global Aptamers Revenue Market Share by Players (2019-2024)
6.2 Global Aptamers Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Aptamers Head office and Area Served
6.4 Global Aptamers Players, Product Type & Application
6.5 Global Aptamers Players, Date of Enter into This Industry
6.6 Global Aptamers Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Aptamers Market Size (2019-2030)
7.2 North America Aptamers Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Aptamers Market Size by Country (2019-2024)
7.4 North America Aptamers Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Aptamers Market Size (2019-2030)
8.2 Europe Aptamers Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Aptamers Market Size by Country (2019-2024)
8.4 Europe Aptamers Market Size by Country (2025-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Aptamers Market Size (2019-2030)
9.2 Asia-Pacific Aptamers Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Aptamers Market Size by Country (2019-2024)
9.4 Asia-Pacific Aptamers Market Size by Country (2025-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Aptamers Market Size (2019-2030)
10.2 Latin America Aptamers Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Aptamers Market Size by Country (2019-2024)
10.4 Latin America Aptamers Market Size by Country (2025-2030)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Aptamers Market Size (2019-2030)
11.2 Middle East & Africa Aptamers Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Aptamers Market Size by Country (2019-2024)
11.4 Middle East & Africa Aptamers Market Size by Country (2025-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 TriLink BioTechnologies
11.1.1 TriLink BioTechnologies Company Detail
11.1.2 TriLink BioTechnologies Business Overview
11.1.3 TriLink BioTechnologies Aptamers Introduction
11.1.4 TriLink BioTechnologies Revenue in Aptamers Business (2017-2022)
11.1.5 TriLink BioTechnologies Recent Development
11.2 AptaBharat
11.2.1 AptaBharat Company Detail
11.2.2 AptaBharat Business Overview
11.2.3 AptaBharat Aptamers Introduction
11.2.4 AptaBharat Revenue in Aptamers Business (2017-2022)
11.2.5 AptaBharat Recent Development
11.3 SomaLogic
11.3.1 SomaLogic Company Detail
11.3.2 SomaLogic Business Overview
11.3.3 SomaLogic Aptamers Introduction
11.3.4 SomaLogic Revenue in Aptamers Business (2017-2022)
11.3.5 SomaLogic Recent Development
11.4 AM Biotechnologies
11.4.1 AM Biotechnologies Company Detail
11.4.2 AM Biotechnologies Business Overview
11.4.3 AM Biotechnologies Aptamers Introduction
11.4.4 AM Biotechnologies Revenue in Aptamers Business (2017-2022)
11.4.5 AM Biotechnologies Recent Development
11.5 Aptamer Sciences
11.5.1 Aptamer Sciences Company Detail
11.5.2 Aptamer Sciences Business Overview
11.5.3 Aptamer Sciences Aptamers Introduction
11.5.4 Aptamer Sciences Revenue in Aptamers Business (2017-2022)
11.5.5 Aptamer Sciences Recent Development
11.6 Base Pair Biotechnologies
11.6.1 Base Pair Biotechnologies Company Detail
11.6.2 Base Pair Biotechnologies Business Overview
11.6.3 Base Pair Biotechnologies Aptamers Introduction
11.6.4 Base Pair Biotechnologies Revenue in Aptamers Business (2017-2022)
11.6.5 Base Pair Biotechnologies Recent Development
11.7 Aptamer Group
11.7.1 Aptamer Group Company Detail
11.7.2 Aptamer Group Business Overview
11.7.3 Aptamer Group Aptamers Introduction
11.7.4 Aptamer Group Revenue in Aptamers Business (2017-2022)
11.7.5 Aptamer Group Recent Development
11.8 Aptagen
11.8.1 Aptagen Company Detail
11.8.2 Aptagen Business Overview
11.8.3 Aptagen Aptamers Introduction
11.8.4 Aptagen Revenue in Aptamers Business (2017-2022)
11.8.5 Aptagen Recent Development
11.9 Aptus Biotech
11.9.1 Aptus Biotech Company Detail
11.9.2 Aptus Biotech Business Overview
11.9.3 Aptus Biotech Aptamers Introduction
11.9.4 Aptus Biotech Revenue in Aptamers Business (2017-2022)
11.9.5 Aptus Biotech Recent Development
11.10 NeoVentures Biotechnology
11.10.1 NeoVentures Biotechnology Company Detail
11.10.2 NeoVentures Biotechnology Business Overview
11.10.3 NeoVentures Biotechnology Aptamers Introduction
11.10.4 NeoVentures Biotechnology Revenue in Aptamers Business (2017-2022)
11.10.5 NeoVentures Biotechnology Recent Development
11.11 Ray Biotech
11.11.1 Ray Biotech Company Detail
11.11.2 Ray Biotech Business Overview
11.11.3 Ray Biotech Aptamers Introduction
11.11.4 Ray Biotech Revenue in Aptamers Business (2017-2022)
11.11.5 Ray Biotech Recent Development
11.12 Vivonics
11.12.1 Vivonics Company Detail
11.12.2 Vivonics Business Overview
11.12.3 Vivonics Aptamers Introduction
11.12.4 Vivonics Revenue in Aptamers Business (2017-2022)
11.12.5 Vivonics Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Aptamers Market Size by Type (2019-2024) & (US$ Million)
Table 6. Global Aptamers Revenue Market Share by Type (2019-2024)
Table 7. Global Aptamers Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 8. Global Aptamers Revenue Market Share by Type (2025-2030)
Table 9. Global Aptamers Market Size by Application (2019-2024) & (US$ Million)
Table 10. Global Aptamers Revenue Market Share by Application (2019-2024)
Table 11. Global Aptamers Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 12. Global Aptamers Revenue Market Share by Application (2025-2030)
Table 13. Global Aptamers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Aptamers Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Aptamers Market Share by Region (2019-2024)
Table 16. Global Aptamers Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Aptamers Market Share by Region (2025-2030)
Table 18. Aptamers Market Trends
Table 19. Aptamers Market Drivers
Table 20. Aptamers Market Challenges
Table 21. Aptamers Market Restraints
Table 22. Global Top Aptamers Manufacturers by Revenue (US$ Million) & (2019-2024)
Table 23. Global Aptamers Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Aptamers Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 25. Global Key Players of Aptamers, Headquarters and Area Served
Table 26. Global Aptamers Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Aptamers by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Aptamers Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. North America Aptamers Market Size by Country (2019-2024) & (US$ Million)
Table 32. North America Aptamers Market Size by Country (2025-2030) & (US$ Million)
Table 33. Europe Aptamers Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Europe Aptamers Market Size by Country (2019-2024) & (US$ Million)
Table 35. Europe Aptamers Market Size by Country (2025-2030) & (US$ Million)
Table 36. Asia-Pacific Aptamers Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Asia-Pacific Aptamers Market Size by Country (2019-2024) & (US$ Million)
Table 38. Asia-Pacific Aptamers Market Size by Country (2025-2030) & (US$ Million)
Table 39. Latin America Aptamers Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 40. Latin America Aptamers Market Size by Country (2019-2024) & (US$ Million)
Table 41. Latin America Aptamers Market Size by Country (2025-2030) & (US$ Million)
Table 42. Middle East & Africa Aptamers Market Growth Rate by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 43. Middle East & Africa Aptamers Market Size by Country (2019-2024) & (US$ Million)
Table 44. Middle East & Africa Aptamers Market Size by Country (2025-2030) & (US$ Million)
Table 45. TriLink BioTechnologies Company Detail
Table 46. TriLink BioTechnologies Business Overview
Table 47. TriLink BioTechnologies Aptamers Product
Table 48. TriLink BioTechnologies Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 49. TriLink BioTechnologies Recent Development
Table 50. AptaBharat Company Detail
Table 51. AptaBharat Business Overview
Table 52. AptaBharat Aptamers Product
Table 53. AptaBharat Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 54. AptaBharat Recent Development
Table 55. SomaLogic Company Detail
Table 56. SomaLogic Business Overview
Table 57. SomaLogic Aptamers Product
Table 58. SomaLogic Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 59. SomaLogic Recent Development
Table 60. AM Biotechnologies Company Detail
Table 61. AM Biotechnologies Business Overview
Table 62. AM Biotechnologies Aptamers Product
Table 63. AM Biotechnologies Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 64. AM Biotechnologies Recent Development
Table 65. Aptamer Sciences Company Detail
Table 66. Aptamer Sciences Business Overview
Table 67. Aptamer Sciences Aptamers Product
Table 68. Aptamer Sciences Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 69. Aptamer Sciences Recent Development
Table 70. Base Pair Biotechnologies Company Detail
Table 71. Base Pair Biotechnologies Business Overview
Table 72. Base Pair Biotechnologies Aptamers Product
Table 73. Base Pair Biotechnologies Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 74. Base Pair Biotechnologies Recent Development
Table 75. Aptamer Group Company Detail
Table 76. Aptamer Group Business Overview
Table 77. Aptamer Group Aptamers Product
Table 78. Aptamer Group Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 79. Aptamer Group Recent Development
Table 80. Aptagen Company Detail
Table 81. Aptagen Business Overview
Table 82. Aptagen Aptamers Product
Table 83. Aptagen Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 84. Aptagen Recent Development
Table 85. Aptus Biotech Company Detail
Table 86. Aptus Biotech Business Overview
Table 87. Aptus Biotech Aptamers Product
Table 88. Aptus Biotech Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 89. Aptus Biotech Recent Development
Table 90. NeoVentures Biotechnology Company Detail
Table 91. NeoVentures Biotechnology Business Overview
Table 92. NeoVentures Biotechnology Aptamers Product
Table 93. NeoVentures Biotechnology Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 94. NeoVentures Biotechnology Recent Development
Table 95. Ray Biotech Company Detail
Table 96. Ray Biotech Business Overview
Table 97. Ray Biotech AptamersProduct
Table 98. Ray Biotech Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 99. Ray Biotech Recent Development
Table 100. Vivonics Company Detail
Table 101. Vivonics Business Overview
Table 102. Vivonics AptamersProduct
Table 103. Vivonics Revenue in Aptamers Business (2017-2022) & (US$ Million)
Table 104. Vivonics Recent Development
Table 105. TriLink BioTechnologies Company Information
Table 106. TriLink BioTechnologies Business Overview
Table 107. TriLink BioTechnologies Aptamers Revenue in Aptamers Business (2019-2024) & (US$ Million)
Table 108. TriLink BioTechnologies Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 109. TriLink BioTechnologies Recent Development
Table 110. AptaBharat Company Information
Table 111. AptaBharat Business Overview
Table 112. AptaBharat Aptamers Revenue in Aptamers Business (2019-2024) & (US$ Million)
Table 113. AptaBharat Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 114. AptaBharat Recent Development
Table 115. SomaLogic Company Information
Table 116. SomaLogic Business Overview
Table 117. SomaLogic Aptamers Revenue in Aptamers Business (2019-2024) & (US$ Million)
Table 118. SomaLogic Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 119. SomaLogic Recent Development
Table 120. AM Biotechnologies Company Information
Table 121. AM Biotechnologies Business Overview
Table 122. AM Biotechnologies Aptamers Revenue in Aptamers Business (2019-2024) & (US$ Million)
Table 123. AM Biotechnologies Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 124. AM Biotechnologies Recent Development
Table 125. Aptamer Sciences Company Information
Table 126. Aptamer Sciences Business Overview
Table 127. Aptamer Sciences Aptamers Revenue in Aptamers Business (2019-2024) & (US$ Million)
Table 128. Aptamer Sciences Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 129. Aptamer Sciences Recent Development
Table 130. Base Pair Biotechnologies Company Information
Table 131. Base Pair Biotechnologies Business Overview
Table 132. Base Pair Biotechnologies Aptamers Revenue in Aptamers Business (2019-2024) & (US$ Million)
Table 133. Base Pair Biotechnologies Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 134. Base Pair Biotechnologies Recent Development
Table 135. Aptamer Group Company Information
Table 136. Aptamer Group Business Overview
Table 137. Aptamer Group Aptamers Revenue in Aptamers Business (2019-2024) & (US$ Million)
Table 138. Aptamer Group Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 139. Aptamer Group Recent Development
Table 140. Aptagen Company Information
Table 141. Aptagen Business Overview
Table 142. Aptagen Aptamers Revenue in Aptamers Business (2019-2024) & (US$ Million)
Table 143. Aptagen Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 144. Aptagen Recent Development
Table 145. Aptus Biotech Company Information
Table 146. Aptus Biotech Business Overview
Table 147. Aptus Biotech Aptamers Revenue in Aptamers Business (2019-2024) & (US$ Million)
Table 148. Aptus Biotech Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 149. Aptus Biotech Recent Development
Table 150. NeoVentures Biotechnology Company Information
Table 151. NeoVentures Biotechnology Business Overview
Table 152. NeoVentures Biotechnology Aptamers Revenue in Aptamers Business (2019-2024) & (US$ Million)
Table 153. NeoVentures Biotechnology Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 154. NeoVentures Biotechnology Recent Development
Table 155. Ray Biotech Company Information
Table 156. Ray Biotech Business Overview
Table 157. Ray Biotech AptamersRevenue in Aptamers Business (2019-2024) & (US$ Million)
Table 158. Ray Biotech Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio
Table 159. Ray Biotech Recent Development
Table 160. Vivonics Company Information
Table 161. Vivonics Business Overview
Table 162. Vivonics AptamersRevenue in Aptamers Business (2019-2024) & (US$ Million)
Table 163. Vivonics Revenue in Aptamers Business (2019-2024) & (US$ Million) Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings